Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations For Patients With Immune-Mediated Diseases in The United States

media

posted on 2020-11-19, 17:35 authored by Martin Bergman, Pankaj Patel, Naijun Chen, Yonghua Jing, Christopher D. Saffore

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Adalimumab Adherence Citrate Citrate-free Injection-site pain Persistence

Licence

CC BY-NC 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM